Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
AI and Machine Learning
Biotech
Chugai inks $250M deal for Gero’s age-related disease targets
Chugai offered up to $250 million for the chance to develop antibodies against age-related disease targets identified by Gero's AI-driven platform.
Nick Paul Taylor
Jul 7, 2025 3:00am
Siemens Healthineers rolls out helium-sealed 1.5T MRI scanner
Jul 1, 2025 12:00pm
Pfizer expands XtalPi small-molecule discovery collab
Jun 30, 2025 10:00am
Cosmo to connect Medtronic GI Genius with Apple Vision Pro
Jun 25, 2025 4:00pm
J&J launches AI surgery funding competition with Nvidia, AWS
Jun 25, 2025 10:30am
Caris Life Sciences ups IPO to raise $494M
Jun 18, 2025 11:00am
